Your browser doesn't support javascript.
loading
SARS-CoV-2 Omicron Variant Wave in India: Advent, Phylogeny and Evolution
Urvashi B Singh; Sushanta Deb; Rama Chaudhry; Kiran Bala; Lata Rani; Ritu Gupta; Lata Kumari; Jawed Ahmed; Sudesh Gaurav; Sowjanya Perumalla; Md. Nizam; Anwita Mishra; J. Stephenraj; Jyoti Shukla; Deepika Bhardwaj; Jamshed Nayer; Praveen Aggarwal; Madhulika Kabra; Vineet Ahuja; Subrata Sinha; Randeep Guleria.
Afiliação
  • Urvashi B Singh; All India Institute of Medical Sciences
  • Sushanta Deb; All India institute of medical sciences
  • Rama Chaudhry; All India Institute of Medical Sciences
  • Kiran Bala; All India Institute of Medical Sciences
  • Lata Rani; All India Institute Of Medical Sciences
  • Ritu Gupta; All India Institute Of Medical Sciences
  • Lata Kumari; All India Institute Of Medical Sciences
  • Jawed Ahmed; All India Institute Of Medical Sciences
  • Sudesh Gaurav; All India Institute Of Medical Sciences
  • Sowjanya Perumalla; All India Institute Of Medical Sciences
  • Md. Nizam; All India Institute Of Medical Sciences
  • Anwita Mishra; All India Institute Of Medical Sciences
  • J. Stephenraj; All India Institute Of Medical Sciences
  • Jyoti Shukla; All India Institute Of Medical Sciences
  • Deepika Bhardwaj; All India Institute Of Medical Sciences
  • Jamshed Nayer; All India Institute Of Medical Sciences
  • Praveen Aggarwal; All India Institute Of Medical Sciences
  • Madhulika Kabra; All India Institute Of Medical Sciences
  • Vineet Ahuja; All India Institute Of Medical Sciences
  • Subrata Sinha; All India Institute of Medical Sciences
  • Randeep Guleria; All India Institute of Medical Sciences
Preprint em En | PREPRINT-BIORXIV | ID: ppbiorxiv-491911
ABSTRACT
SARS-CoV-2 evolution has continued to generate variants, responsible for new pandemic waves locally and globally. Varying disease presentation and severity has been ascribed to inherent variant characteristics and vaccine immunity. This study analyzed genomic data from 305 whole genome sequences from SARS-CoV-2 patients before and through the third wave in India. Delta variant was responsible for disease in patients without comorbidity(97%), while Omicron BA.2 caused disease primarily in those with comorbidity(77%). Tissue adaptation studies brought forth higher propensity of Omicron variants to bronchial tissue than lung, contrary to observation in Delta variants from Delhi. Study of codon usage pattern distinguished the prevalent variants, clustering them separately, Omicron BA.2 isolated in February grouped away from December strains, and all BA.2 after December acquired a new mutation S959P in ORF1b (44.3% of BA.2 in the study) indicating ongoing evolution. Loss of critical spike mutations in Omicron BA.2 and gain of immune evasion mutations including G142D, reported in Delta but absent in BA.1, and S371F instead of S371L in BA.1 could possibly be due to evolutionary trade-off and explain very brief period of BA.1 in December 2021, followed by complete replacement by BA.2.
Licença
cc_no
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-BIORXIV Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Preprint
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-BIORXIV Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Preprint